相关实验视频

Updated: Jun 29, 2025

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Herbal Munziq Ameliorates Myocardial Ischemia-Reperfusion Injury by Inhibiting Inflammation

Published on: January 10, 2025

米里卡诺尔通过核因子红色素2相关因子2信号传递和核因子kappa B/mitogen激活蛋白激酶通路通过上调Sirtuin 1减弱败血症诱导的炎症反应

Kaiyuan Liu^1,2, Liuye Yang^1,2, Pengchao Wang^1,2

¹Clinic Center of Human Gene Research, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1277 Jiefang Ave, Wuhan, 430022, China.

Inflammopharmacology

|March 25, 2024

概括

一种天然化合物Myricanol通过激活Sirtuin 1 (SIRT1) 来显示出对败血症的治疗潜力. 它减少了炎症和氧化应激,改善了毒症模型中的生存率.

科学领域:

生物化学生化学
免疫学免疫学免疫学
药理学药理学是一个学科.

背景情况:

败血症是一种危及生命的疾病,由失调的免疫反应引起.
米里卡诺尔是一种天然化合物,具有潜在的Sirtuin 1 (SIRT1) 激活特性.
目前的败血症治疗方法面临着重大的临床挑战.

研究的目的:

在脂聚糖 (LPS) 诱导的败血症模型中研究米瑞卡诺的治疗潜力.
为了阐明myricanol在败血症中的作用的潜在机制.

主要方法:

使用LPS治疗的小鼠进行体内研究,以评估生存率和炎症反应.
在实验室中对巨细胞进行研究,以评估细胞因子表达,信号通路激活和氧化应激.
进行SIRT1激活和沉默实验,包括使用SIRT1骨髓特异性淘汰小鼠.

主要成果:

在接受LPS治疗的小鼠中,Myricanol显著提高了生存率,并减少了肺炎.
在体外,myricanol抑制了促炎性细胞因子,减弱了信号通路,并减少了巨细胞中的氧化应激.
米里卡诺尔选择性地增强了SIRT1的激活,其保护作用取决于SIRT1.

结论:

米里卡诺尔作为一种强大的SIRT1激活剂,抑制过度的炎症反应.
米里卡诺尔向炎症信号通路和氧化应激,证明了败血症的治疗潜力.
这些发现突出了myricanol作为一个有前途的新型治疗剂LPS诱导的败血症.

关键词:

炎症炎症是一种炎症.这就是Myricanol.氧化应激是一种氧化应激.一个SIRT1系统.败血症这是一种败血症.

更多相关视频

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies

Published on: April 11, 2012

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury

Published on: March 7, 2022

相关概念视频

Regulation of the Unfolded Protein Response

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...

NF-κB-dependent Signaling Pathway

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...